Good news for San Jose Sharks regarding injuries.

The San Jose Sharks start off this week with some promising news on the injury front. Coach Ryan Warsofsky gave updates on the injuries of Thomas Bordeleau, Shakir Mukhamadullin, and Macklin Celebrini before their game against the Colorado Avalanche on Sunday at SAP Center. It seems that Bordeleau and Mukhamadullin, who were previously considered week-to-week, are now listed as day-to-day. Additionally, Celebrini has started skating again after being off the ice for about a week since his NHL debut on October 10th.

Bordeleau suffered a lower-body injury early on in training camp and was placed on injured reserve at the beginning of the regular season. Similarly, Mukhamadullin was injured during a practice in mid-September and has since been skating with a group of injured players, although he did participate in an optional skate in the first week of October. Coach Warsofsky noted that their recovery timelines are similar, which is a positive sign for their return to the ice.

Mukhamadullin and fellow defenseman Marc-Edouard Vlasic are currently listed as injured/non-roster players. As for Celebrini, he is still considered week-to-week with no set timetable for his return. However, the fact that he is skating again is a positive indication of his progress. Celebrini has been dealing with a hip injury since training camp, which was exacerbated during a preseason game on October 1st. Despite this setback, he was able to make his NHL debut on October 10th and even recorded a goal and an assist in a close overtime loss to the St. Louis Blues.

Unfortunately, the Sharks have yet to secure a win this season as they head into Sunday's game against the Avalanche. Looking ahead, they have a tough four-game road trip coming up with stops in Anaheim, Los Angeles, Las Vegas, and Utah. It will be a challenging journey, but the team is determined to turn their season around and come back stronger.

[This article has been trending online recently and has been generated with AI. Your feed is customized.]
[Generative AI is experimental.]